Biotransformation yields novel metabolites from oleanonic acid, showing potential anti-neuroinflammatory activity in BV-2 cells.
Biotransformation of oleanonic acid by Circinella muscae CGMCC 3.2695 yielded two novel 11, 12-epoxidized and 13, 28-lactonized metabolites (compounds 5 and 6) alongside four previously identified compounds. Structural elucidation was conducted through comprehensive spectroscopic analyses and single-crystal X-ray diffraction. The fungus C. muscae demonstrates catalytic capability in mediating the structural transformation of oleanonic acid, facilitating the generation of both 11α, 12α- and 11β, 12β-trimeric oxygen-containing cyclic structures, in addition to producing 13β, 28β-lactone derivatives. Furthermore, the potential anti-neuroinflammatory activity of metabolites was investigated by assessing their ability to inhibit nitric oxide (NO) production in BV-2 microglial cells stimulated by lipopolysaccharide (LPS). Compounds 1, 2, and 6 exhibited significant inhibitory effects, with IC50 values of 25.70, 34.64, and 5.25, respectively. These results suggested that biotransformation derivatives of oleanonic acid might be served as potential neuroinflammatory inhibitors.
No takes yet. Share an insight, caveat, or question.
We et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: